Home / Lifestyle / Health & Fitness / Article /
Indian study shows Covid XBB.1.16 raising conjunctivitis risk in infants
Updated On: 24 April, 2023 09:13 AM IST | New Delhi | IANS
Amid the recent rise in Covid-19 cases in India, driven by the subvariant of Omicron XBB.1.16, there has been an increase in risk of conjunctivitis among children aged below one-year, according to a study, not yet peer-reviewed
Listen to this article :
Image for representational purposes only. Photo Courtesy: iStock
Amid the recent rise in Covid-19 cases in India, driven by the subvariant of Omicron XBB.1.16, there has been an increase in risk of conjunctivitis among children aged below one-year, according to a study, not yet peer-reviewed.
The study, led by Vipin M. Vashishtha, member of WHO`s Vaccine Safety Net, is based on 25 children seen in OPD of a paediatric hospital in Uttar Pradesh between April 4-16.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT